HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nathalie A Lokker Selected Research

Nathalie A Lokker Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
05/2013 - 01/2013
2Neutropenia
05/2013 - 01/2013
2Neointima
09/2002 - 07/2002
1Stomatitis
05/2013
1Fatigue
05/2013
1Peripheral Nervous System Diseases (PNS Diseases)
05/2013
1Colorectal Neoplasms (Colorectal Cancer)
05/2013
1Liver Diseases (Liver Disease)
01/2013
1Malaria
01/2013
1Glioblastoma (Glioblastoma Multiforme)
07/2002
1Glioma (Gliomas)
07/2002
1Neoplasms (Cancer)
07/2002
1Brain Neoplasms (Brain Tumor)
07/2002
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2002

Drug/Important Bio-Agent (IBA)

3Sorafenib (BAY 43-9006)FDA Link
05/2013 - 01/2013
2human ERBB2 proteinIBA
05/2013 - 01/2013
1Capecitabine (Xeloda)FDA Link
05/2013
1Bevacizumab (Avastin)FDA Link
05/2013
1GemcitabineFDA Link
05/2013
1Fluorouracil (Carac)FDA LinkGeneric
05/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2013
1Leucovorin (Folinic Acid)FDA Link
05/2013
1Paclitaxel (Taxol)FDA LinkGeneric
01/2013
1Becaplermin (PDGF-BB)FDA Link
09/2002
1LigandsIBA
07/2002
1Platelet-Derived Growth FactorIBA
07/2002
1platelet-derived growth factor C (PDGF-C)IBA
07/2002
1platelet-derived growth factor AIBA
07/2002
1CT52923IBA
07/2002
1tandutinibIBA
06/2002
1Phosphotransferases (Kinase)IBA
06/2002

Therapy/Procedure

3Therapeutics
01/2013 - 06/2002
2Oral Administration
09/2002 - 07/2002
1Drug Tapering
05/2013
1Catheters
07/2002